$SLGL 3 SEC Filings

Filed On	Filing
18 Mar 2026	Form 3: Yosef Itzik, Chief Operating Officer
18 Mar 2026	Form 3: Ben-Or Eyal, Chief Financial Officer Holds 1,000 shares of Ordinary Shares
18 Mar 2026	Form 3: Gottfried Ran, Director Holds 1,550 shares of Ordinary shares
18 Mar 2026	Form 3: Kochan Sharon, Director
18 Mar 2026	Form 3: Yanai Yuval, Director
18 Mar 2026	Form 3: Lerman Hanna, Director
18 Mar 2026	Form 3: Arkin Itai Gidon, Director No securities owned
18 Mar 2026	Form 3: Glezin Michael, Chief Business Officer Holds 1,500 shares of Ordinary Shares
18 Mar 2026	Form 3: Levy-Hacham Ofra, VP Clinical, Reg & Quality
18 Mar 2026	Form 3: Toledano Ofer, VP Research & Dev. Holds 1,461 shares of Ordinary Shares
18 Mar 2026	Form 3: Arkin Moshe, Director Holds 143,257 shares of Ordinary Shares
17 Nov 2025	Form 3: Opaleye Management Inc., 10% owner Holds 357,367 shares of Ordinary Shares, par value NIS 1.00 per share

Comments